Biogen Inc. (BIIB)

Biogen Inc. (BIIB) scores 48 out of 100 (around average among 99 US stocks) on trend, risk, fundamentals, market backdrop and news tone. Every calculation step shown. Educational, not advice.

• Trend: 88/100
• Risk: 61/100
• Fundamentals: 13/100
• Backdrop: 45/100
• News: 32/100

BIIB scores 47.9 out of 100 (around average), down 8.4 points from last week. Its price trend adds the most (+7.6 points: price is +10.6% vs its 100-day average). Its fundamentals weigh on it most (-7.4 points: revenue growth vs a year earlier: +1.9%). Our research found no proven record of these factors predicting returns.

Sector: Health care. Data as of 2026-10-19.